The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Open accessAbstract
Thousands of mutations are identified yearly. Although many directly affect protein expression, an increasing proportion of mutations is now believed to influence mRNA splicing. They mostly affect existing splice sites, but synonymous, non-synonymous or nonsense mutations can also create or disrupt splice sites or auxiliary cis-splicing sequences. To facilitate the analysis of the different mutations, we designed Human Splicing Finder (HSF), a tool to predict the effects of mutations on splicing signals or to identify splicing motifs in any human sequence. It contains all available matrices for auxiliary sequence prediction as well as new ones for binding sites of the 9G8 and Tra2-beta Serine-Arginine proteins and the hnRNP A1 ribonucleoprotein. We also developed new Position Weight Matrices to assess the strength of 5' and 3' splice sites and branch points. We evaluated HSF efficiency using a set of 83 intronic and 35 exonic mutations known to result in splicing defects. We showed that the mutation effect was correctly predicted in almost all cases. HSF could thus represent a valuable resource for research, diagnostic and therapeutic (e.g. therapeutic exon skipping) purposes as well as for global studies, such as the GEN2PHEN European Project or the Human Variome Project.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617 · cited 1×
“Sequences were aligned with ClustalW (33) to generate a consensus motif.”
MethodMEME: discovering and analyzing DNA and protein sequence motifs
Bailey, T. L., Williams, N., Misleh, C., & Li, W. W. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl198 · Cited by 2,670
Shapiro, M. B., & Senapathy, P. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.17.7155 · Cited by 2,275
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209 · cited 1×
“Understanding how splicing is regulated is thus crucial, particularly in a medical context, since genomic variations which cause aberrant splicing may represent up to 50% of all mutations that lead to gene dysfunction (6).”
BackgroundMaximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals
Yeo, G., & Burge, C. B. (2004) · Journal of Computational Biology · doi:10.1089/1066527041410418 · Cited by 2,033
The UCSC Genome Browser Database
Karolchik, D. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg129 · Cited by 1,887
Loeys, B. L., Chen, J., Neptune, E. R., Judge, D. P., Podowski, M., Holm, T., Meyers, J., Leitch, C. C., Katsanis, N., Sharifi, N., et al. (2005) · Nature Genetics · doi:10.1038/ng1511 · Cited by 1,795
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion
Dunnen, J. T. D., & Antonarakis, S. E. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<7::aid-humu4>3.0.co;2-n · Cited by 1,756
Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor
Loeys, B. L., Schwarze, U., Holm, T., Callewaert, B. L., Thomas, G. H., Pannu, H., De Backer, J. F., Oswald, G. L., Symoens, S., Manouvrier, S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055695 · Cited by 1,663
ESEfinder: a web resource to identify exonic splicing enhancers
Cartegni, L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg616 · Cited by 1,603
Research works printed but not linked: 20
- Yuan, 1999, Comparison of heteroduplex analysis, direct sequencing, and enzyme mismatch cleavage for detecting mutations in a large gene, FBN1, Hum. Mutat., 14, 440, 10.1002/(SICI)1098-1004(199911)14:5<440::AID-HUMU11>3.0.CO;2-P · doi:10.1002/(sici)1098-1004(199911)14:5<440::aid-humu11>3.0.co;2-p
- Rommel, 2002, Mutation screening of the fibrillin-1 (FBN1) gene in 76 unrelated patients with Marfan syndrome or Marfanoid features leads to the identification of 11 novel and three previously reported mutations, Hum. Mutat., 20, 406, 10.1002/humu.9075 · doi:10.1002/humu.9075
- Park, 1998, Clustering of FBN2 mutations in patients with congenital contractural arachnodactyly indicates an important role of the domains encoded by exons 24 through 34 during human development, Am. J. Med. Genet., 78, 350, 10.1002/(SICI)1096-8628(19980724)78:4<350::AID-AJMG9>3.0.CO;2-P · doi:10.1002/(sici)1096-8628(19980724)78:4<350::aid-ajmg9>3.0.co;2-p
- Palz, 2000, Clustering of mutations associated with mild Marfan-like phenotypes in the 3′ region of FBN1 suggests a potential genotype-phenotype correlation, Am. J. Med. Genet., 91, 212, 10.1002/(SICI)1096-8628(20000320)91:3<212::AID-AJMG12>3.0.CO;2-3 · doi:10.1002/(sici)1096-8628(20000320)91:3<212::aid-ajmg12>3.0.co;2-3
- Hutchinson, 2001, Marfan syndrome caused by a mutation in FBN1 that gives rise to cryptic splicing and a 33 nucleotide insertion in the coding sequence, Hum. Genet., 109, 416, 10.1007/s004390100573 · doi:10.1007/s004390100573
- Halliday, 1999, Molecular analysis of eight mutations in FBN1, Hum. Genet., 105, 587, 10.1007/s004399900190 · doi:10.1007/s004399900190
- Gupta, 2002, Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype, Hum. Mutat., 19, 39, 10.1002/humu.10017 · doi:10.1002/humu.10017
- Guo, 2001, FBN1 exon 2 splicing error in a patient with Marfan syndrome, Am. J. Med. Genet., 101, 130, 10.1002/1096-8628(20010615)101:2<130::AID-AJMG1333>3.0.CO;2-V · doi:10.1002/1096-8628(20010615)101:2<130::aid-ajmg1333>3.0.co;2-v
- Comeglio, 2007, The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutations, Hum. Mutat., 28, 928, 10.1002/humu.9505 · doi:10.1002/humu.9505
- Chikumi, 2000, Fibrillin gene (FBN1) mutations in Japanese patients with Marfan syndrome, J. Hum. Genet., 45, 115, 10.1007/s100380050027 · doi:10.1007/s100380050027
- Biggin, 2004, Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy, Hum. Mutat., 23, 99, 10.1002/humu.9207 · doi:10.1002/humu.9207
- Attanasio, 2008, FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations, Clin. Genet., 74, 39, 10.1111/j.1399-0004.2008.01007.x · doi:10.1111/j.1399-0004.2008.01007.x
- Ng, 2008, Genetic regulation of MUC1 alternative splicing in human tissues, Br. J. Cancer, 99, 978, 10.1038/sj.bjc.6604617 · doi:10.1038/sj.bjc.6604617
- Habara, 2008, A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract, J. Biochem., 143, 303, 10.1093/jb/mvm227 · doi:10.1093/jb/mvm227
- Booms, 1999, Novel exon skipping mutation in the fibrillin-1 gene: two ‘hot spots’ for the neonatal Marfan syndrome, Clin. Genet., 55, 110, 10.1034/j.1399-0004.1999.550207.x · doi:10.1034/j.1399-0004.1999.550207.x
- Wang, 1995, Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome, Hum. Mol. Genet., 4, 607, 10.1093/hmg/4.4.607 · doi:10.1093/hmg/4.4.607
- Maslen, 1997, A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly, Am. J. Hum. Genet., 60, 1389, 10.1086/515472 · doi:10.1086/515472
- Vivenza, 2006, A novel deletion in the GH1 gene including the IVS3 branch site responsible for autosomal dominant isolated growth hormone deficiency, J. Clin. Endocrinol. Metab., 91, 980, 10.1210/jc.2005-1703 · doi:10.1210/jc.2005-1703
- Vuillaumier-Barrot, 2006, PMM2 intronic branch-site mutations in CDG-Ia, Mol. Genet. Metab., 87, 337, 10.1016/j.ymgme.2005.10.015 · doi:10.1016/j.ymgme.2005.10.015
- Janssen, 2000, A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder, Ann Hum. Genet., 64, 375, 10.1046/j.1469-1809.2000.6450375.x · DOI
Cited by
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Li, M. M., Datto, M., Duncavage, E. J., Kulkarni, S., Lindeman, N. I., Roy, S., Tsimberidou, A. M., Vnencak-Jones, C. L., Wolff, D. J., Younes, A., et al. (2017) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.10.002 · Cited by 2,030
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799
Association analysis identifies 65 new breast cancer risk loci
Michailidou, K., Lindström, S., Dennis, J., Beesley, J., Hui, S., Kar, S., Lemaçon, A., Soucy, P., Glubb, D., Rostamianfar, A., et al. (2017) · Nature · doi:10.1038/nature24284 · Cited by 1,413
Accurate classification of BRCA1 variants with saturation genome editing
Findlay, G. M., Daza, R. M., Martin, B., Zhang, M. D., Leith, A. P., Gasperini, M., Janizek, J. D., Huang, X., Starita, L. M., & Shendure, J. (2018) · Nature · doi:10.1038/s41586-018-0461-z · Cited by 843
Improving genetic diagnosis in Mendelian disease with transcriptome sequencing
Cummings, B. B., Marshall, J. L., Tukiainen, T., Lek, M., Donkervoort, S., Foley, A. R., Bolduc, V., Waddell, L. B., Sandaradura, S. A., O’Grady, G. L., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal5209 · Cited by 831
Bouaoun, L., Sonkin, D., Ardin, M., Hollstein, M., Byrnes, G., Zavadil, J., & Olivier, M. (2016) · Human Mutation · doi:10.1002/humu.23035 · Cited by 730
Splicing mutations in human genetic disorders: Examples, detection, and confirmation
Anna, A., & Monika, G. (2018) · Journal of Applied Genetics · doi:10.1007/s13353-018-0444-7 · Cited by 657
Paediatric genomics: diagnosing rare disease in children
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.116 · Cited by 618
Genetic diagnosis of Mendelian disorders via RNA sequencing
Kremer, L. S., Bader, D. M., Mertes, C., Kopajtich, R., Pichler, G., Iuso, A., Haack, T. B., Graf, E., Schwarzmayr, T., Terrile, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15824 · Cited by 590
In silico prediction of splice-altering single nucleotide variants in the human genome
Jian, X., Boerwinkle, E., & Liu, X. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1206 · Cited by 537
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (UK), Loveday, C., Turnbull, C., Ramsay, E., Hughes, D., Ruark, E., Frankum, J. R., Bowden, G., Kalmyrzaev, B., Warren-Perry, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.893 · Cited by 534
Study, A. C., Bojesen, S. E., Study, A. O. C., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), (GENICA), G. E. I. A. B. C., (SWE-BRCA), S. B. C. S., The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), (EMBRACE), E. S. O. B. &. B. M. C., (GEMO), G. M. O. C. R. I. B. M. C., Pooley, K. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2566 · Cited by 528
Endele, S., Rosenberger, G., Geider, K., Popp, B., Tamer, C., Stefanova, I., Milh, M., Kortüm, F., Fritsch, A., Pientka, F. K., et al. (2010) · Nature Genetics · doi:10.1038/ng.677 · Cited by 499
Carss, K. J., Arno, G., Erwood, M., Stephens, J., Sanchis-Juan, A., Hull, S., Megy, K., Grozeva, D., Dewhurst, E., Malka, S., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.12.003 · Cited by 463
De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia
Xu, B., Ionita-Laza, I., Roos, J. L., Boone, B., Woodrick, S., Sun, Y., Levy, S., Gogos, J. A., & Karayiorgou, M. (2012) · Nature Genetics · doi:10.1038/ng.2446 · Cited by 442
Lesage, S., Drouet, V., Majounie, E., Deramecourt, V., Jacoupy, M., Nicolas, A., Cormier-Dequaire, F., Hassoun, S. M., Pujol, C., Ciura, S., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.01.014 · Cited by 434
Hunt, R. C., Simhadri, V. L., Iandoli, M., Sauna, Z. E., & Kimchi-Sarfaty, C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.04.006 · Cited by 389
College of American Pathologists' Laboratory Standards for Next-Generation Sequencing Clinical Tests
Aziz, N., Zhao, Q., Bry, L., Driscoll, D. K., Funke, B., Gibson, J. S., Grody, W. W., Hegde, M. R., Hoeltge, G. A., Leonard, D. G. B., et al. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0250-cp · Cited by 387
Alsafadi, S., Houy, A., Battistella, A., Popova, T., Wassef, M., Henry, E., Tirode, F., Constantinou, A., Piperno-Neumann, S., Roman-Roman, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10615 · Cited by 386
Oligogenic basis of isolated gonadotropin-releasing hormone deficiency
Sykiotis, G. P., Plummer, L., Hughes, V. A., Au, M., Durrani, S., Nayak-Young, S., Dwyer, A. A., Quinton, R., Hall, J. E., Gusella, J. F., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009622107 · Cited by 360
A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition
Whittaker, S. R., Theurillat, J.-P., Van Allen, E., Wagle, N., Hsiao, J., Cowley, G. S., Schadendorf, D., Root, D. E., & Garraway, L. A. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0470 · Cited by 359
A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression
Grelet, S., Link, L. A., Howley, B., Obellianne, C., Palanisamy, V., Gangaraju, V. K., Diehl, J. A., & Howe, P. H. (2017) · Nature Cell Biology · doi:10.1038/ncb3595 · Cited by 357
Funayama, M., Ohe, K., Amo, T., Furuya, N., Yamaguchi, J., Saiki, S., Li, Y., Ogaki, K., Ando, M., Yoshino, H., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70266-2 · Cited by 351
Amit, M., Donyo, M., Hollander, D., Goren, A., Kim, E., Gelfman, S., Lev-Maor, G., Burstein, D., Schwartz, S., Postolsky, B., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.03.013 · Cited by 338
Targeted next generation sequencing as a diagnostic tool in epileptic disorders
Lemke, J. R., Riesch, E., Scheurenbrand, T., Schubach, M., Wilhelm, C., Steiner, I., Hansen, J., Courage, C., Gallati, S., Bürki, S., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03516.x · Cited by 332
Mensenkamp, A. R., Vogelaar, I. P., van Zelst–Stams, W. A. G., Goossens, M., Ouchene, H., Hendriks–Cornelissen, S. J. B., Kwint, M. P., Hoogerbrugge, N., Nagtegaal, I. D., & Ligtenberg, M. J. L. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.002 · Cited by 328
Fotiou, E., Martin-Almedina, S., Simpson, M. A., Lin, S., Gordon, K., Brice, G., Atton, G., Jeffery, I., Rees, D. C., Mignot, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9085 · Cited by 327
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Burnichon, N., Vescovo, L., Amar, L., Libé, R., de Reynies, A., Venisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr324 · Cited by 309
Prevalence of mutations in LEP, LEPR, and MC4R genes in individuals with severe obesity
Paolini, B., Maltese, P. E., Del Ciondolo, I., Tavian, D., Missaglia, S., Ciuoli, C., Zuntini, M., Cecchin, S., Bertelli, M., & Pompucci, G. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15038718 · Cited by 308
Yu, T. W., Mochida, G. H., Tischfield, D. J., Sgaier, S. K., Flores-Sarnat, L., Sergi, C. M., Topçu, M., McDonald, M. T., Barry, B. J., Felie, J. M., et al. (2010) · Nature Genetics · doi:10.1038/ng.683 · Cited by 297
Bioinformatics and Computational Tools for Next-Generation Sequencing Analysis in Clinical Genetics
Pereira, R., Oliveira, J., & Sousa, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010132 · Cited by 279
SpliceAid 2: a database of human splicing factors expression data and RNA target motifs
Piva, F., Giulietti, M., Burini, A. B., & Principato, G. (2012) · Human Mutation · doi:10.1002/humu.21609 · Cited by 256
Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity
Souma, T., Tompson, S. W., Thomson, B. R., Siggs, O. M., Kizhatil, K., Yamaguchi, S., Feng, L., Limviphuvadh, V., Whisenhunt, K. N., Maurer-Stroh, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85830 · Cited by 259
STAT2 deficiency and susceptibility to viral illness in humans
Hambleton, S., Goodbourn, S., Young, D. F., Dickinson, P., Mohamad, S. M. B., Valappil, M., McGovern, N., Cant, A. J., Hackett, S. J., Ghazal, P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220098110 · Cited by 255
Flück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248
Houdayer, C., Caux-Moncoutier, V., Krieger, S., Barrois, M., Bonnet, F., Bourdon, V., Bronner, M., Buisson, M., Coulet, F., Gaildrat, P., et al. (2012) · Human Mutation · doi:10.1002/humu.22101 · Cited by 239
MMSplice: modular modeling improves the predictions of genetic variant effects on splicing
Cheng, J., Nguyen, T. Y. D., Cygan, K. J., Çelik, M. H., Fairbrother, W. G., Avsec, Ž., & Gagneur, J. (2019) · Genome Biology · doi:10.1186/s13059-019-1653-z · Cited by 235
“However, although methods combining several of these scores have been proposed, including Human Splicing Finder [14], MutPred splice [15], and more recently SPiCE [16], the resulting physical and quantitative effect of these variants on splicing remains difficult to assess with these algorithms.”
MethodExonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder
Krupp, D. R., Barnard, R. A., Duffourd, Y., Evans, S. A., Mulqueen, R. M., Bernier, R., Rivière, J.-B., Fombonne, E., & O’Roak, B. J. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.07.016 · Cited by 204
Chakraborty, P. K., Schmitz-Abe, K., Kennedy, E. K., Mamady, H., Naas, T., Durie, D., Campagna, D. R., Lau, A., Sendamarai, A. K., Wiseman, D. H., et al. (2014) · Blood · doi:10.1182/blood-2014-08-591370 · Cited by 190
Symoens, S., Syx, D., Malfait, F., Callewaert, B., De Backer, J., Vanakker, O., Coucke, P., & De Paepe, A. (2012) · Human Mutation · doi:10.1002/humu.22137 · Cited by 165
Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects
Seong, E., Insolera, R., Dulovic, M., Kamsteeg, E., Trinh, J., Brüggemann, N., Sandford, E., Li, S., Ozel, A. B., Li, J. Z., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25220 · Cited by 163
In silico tools for splicing defect prediction: a survey from the viewpoint of end users
Jian, X., Boerwinkle, E., & Liu, X. (2014) · Genetics in Medicine · doi:10.1038/gim.2013.176 · Cited by 146
Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS)
Korvatska, O., Strand, N. S., Berndt, J. D., Strovas, T., Chen, D.-H., Leverenz, J. B., Kiianitsa, K., Mata, I. F., Karakoc, E., Greenup, J. L., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt180 · Cited by 140
Courcet, J.-B., Faivre, L., Malzac, P., Masurel-Paulet, A., Lopez, E., Callier, P., Lambert, L., Lemesle, M., Thevenon, J., Gigot, N., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101251 · Cited by 121
Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease
Oji, Y., Hatano, T., Ueno, S.-I., Funayama, M., Ishikawa, K.-I., Okuzumi, A., Noda, S., Sato, S., Satake, W., Toda, T., et al. (2020) · Brain · doi:10.1093/brain/awaa064 · Cited by 116
Barbosa, S., Greville-Heygate, S., Bonnet, M., Godwin, A., Fagotto-Kaufmann, C., Kajava, A. V., Laouteouet, D., Mawby, R., Wai, H. A., Dingemans, A. J. M., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.01.018 · Cited by 104
Béziat, V., Rapaport, F., Hu, J., Titeux, M., Bonnet des Claustres, M., Bourgey, M., Griffin, H., Bandet, É., Ma, C. S., Sherkat, R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.06.004 · Cited by 95
Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing
Maule, G., Casini, A., Montagna, C., Ramalho, A. S., De Boeck, K., Debyser, Z., Carlon, M. S., Petris, G., & Cereseto, A. (2019) · Nature Communications · doi:10.1038/s41467-019-11454-9 · Cited by 86
Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9
Schmitz-Abe, K., Ciesielski, S. J., Schmidt, P. J., Campagna, D. R., Rahimov, F., Schilke, B. A., Cuijpers, M., Rieneck, K., Lausen, B., Linenberger, M. L., et al. (2015) · Blood · doi:10.1182/blood-2015-09-659854 · Cited by 75
Wang, W., Corominas, R., & Lin, G. N. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00258 · Cited by 70
“One of the most widely used tools, HSF (Desmet et al., 2009), contains more than 10 algorithms including position weight matrices (PWM), maximum entropy principle, and motif comparison method, to identify splicing motifs across the imputed human sequence.”
MethodGenetic variation in APOE cluster region and Alzheimer's disease risk
Cervantes, S., Samaranch, L., Vidal-Taboada, J. M., Lamet, I., Bullido, M. J., Frank-García, A., Coria, F., Lleó, A., Clarimón, J., Lorenzo, E., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.023 · Cited by 62
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers
Kobayashi, Y., Chhoeu, C., Li, J., Price, K. S., Kiedrowski, L. A., Hutchins, J. L., Hardin, A. I., Wei, Z., Hong, F., Bahcall, M., et al. (2022) · Nature · doi:10.1038/s41586-022-04451-4 · Cited by 56
ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration
Hirose, T., Cabrera-Socorro, A., Chitayat, D., Lemonnier, T., Féraud, O., Cifuentes-Diaz, C., Gervasi, N., Mombereau, C., Ghosh, T., Stoica, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci79990 · Cited by 55
“Human Splicing Finder (20) analysis predicted that the deletion disrupts a branch point motif (CTCTTAA) at position c.”
BackgroundInfluentialThe clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations
Rodríguez Cruz, P. M., Cossins, J., de Paula Estephan, E., Munell, F., Selby, K., Hirano, M., Maroofin, R., Mehrjardi, M. Y. V., Chow, G., Carr, A., et al. (2019) · Brain · doi:10.1093/brain/awz107 · Cited by 51
Miyake, N., Wolf, N. I., Cayami, F. K., Crawford, J., Bley, A., Bulas, D., Conant, A., Bent, S. J., Gripp, K. W., Hahn, A., et al. (2017) · neurogenetics · doi:10.1007/s10048-017-0520-x · Cited by 48
“0) tool to predict the impact each of the mutations may have on the splicing of AIFM1 [13].”
InfluentialParp mutations protect from mitochondrial toxicity in Alzheimer’s disease
Yu, Y., Fedele, G., Celardo, I., Loh, S. H. Y., & Martins, L. M. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03926-y · Cited by 46
Microcephaly Modeling of Kinetochore Mutation Reveals a Brain-Specific Phenotype
Omer Javed, A., Li, Y., Muffat, J., Su, K.-C., Cohen, M. A., Lungjangwa, T., Aubourg, P., Cheeseman, I. M., & Jaenisch, R. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.032 · Cited by 46
“We used the Human Splicing Finder bioinformatics tool, which combines 12 different algorithms to calculate effects of the point mutation on other splicing regulatory elements (Desmet et al., 2009).”
MethodNovel DPY19L2 variants in globozoospermic patients and the overcoming this male infertility
Cao, Y.-X., Li, W., Shang, Y.-L., Zhu, F.-X., Yan, J., Chen, L., Tang, W.-H., Xiao, S., Mo, W.-K., Zhang, Z.-G., et al. (2019) · Asian Journal of Andrology · doi:10.4103/aja.aja_79_18 · Cited by 45
Gjesing, A. P., Rui, G., Lauenborg, J., Have, C. T., Hollensted, M., Andersson, E., Grarup, N., Sun, J., Quan, S., Brandslund, I., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00040 · Cited by 43
Celse, T., Cazin, C., Mietton, F., Martinez, G., Martinez, D., Thierry-Mieg, N., Septier, A., Guillemain, C., Beurois, J., Clergeau, A., et al. (2021) · Human Genetics · doi:10.1007/s00439-020-02229-0 · Cited by 42
VIPdb, a genetic variant impact predictor database
Hu, Z., Yu, C., Furutsuki, M., Andreoletti, G., Ly, M., Hoskins, R., Adhikari, A. N., & Brenner, S. E. (2019) · Human Mutation · doi:10.1002/humu.23858 · Cited by 37
Functional Analysis of Two Haplotypes of the Human Endothelial Protein C Receptor Gene
Medina, P., Navarro, S., Bonet, E., Martos, L., Estellés, A., Bertina, R. M., Vos, H. L., & España, F. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302518 · Cited by 35
Torrico, B., Shaw, A. D., Mosca, R., Vivó-Luque, N., Hervás, A., Fernàndez-Castillo, N., Aloy, P., Bayés, M., Fullerton, J. M., Cormand, B., et al. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180184 · Cited by 34
Whiley, P. J., Parsons, M. T., Leary, J., Tucker, K., Warwick, L., Dopita, B., Thorne, H., Lakhani, S. R., Goldgar, D. E., Brown, M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086836 · Cited by 25
Mutations in Proteasome-Related Genes Are Associated with Thyroid Hemiagenesis
Budny, B., Szczepanek-Parulska, E., Zemojtel, T., Szaflarski, W., Rydzanicz, M., Wesoly, J., Handschuh, L., Wolinski, K., Piatek, K., Niedziela, M., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1287-4 · Cited by 22
Vathipadiekal, V., Farrell, J. J., Wang, S., Edward, H. L., Shappell, H., Al‐Rubaish, A. M., Al‐Muhanna, F., Naserullah, Z., Alsuliman, A., Qutub, H. O., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24527 · Cited by 20
Mäkelä, E., Pavic, K., Varila, T., Salmenniemi, U., Löyttyniemi, E., Nagelli, S. G., Ammunét, T., Kähäri, V.-M., Clark, R. E., Elo, L. L., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3679 · Cited by 18
Deep mutational scanning quantifies DNA binding and predicts clinical outcomes of PAX6 variants
McDonnell, A. F., Plech, M., Livesey, B. J., Gerasimavicius, L., Owen, L. J., Hall, H. N., FitzPatrick, D. R., Marsh, J. A., & Kudla, G. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00043-8 · Cited by 16
Stenfelt, L., Hellberg, Å., Möller, M., Thornton, N., Larson, G., & Olsson, M. L. (2019) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2019.100659 · Cited by 15
Giant axonal neuropathy: a multicenter retrospective study with genotypic spectrum expansion
Echaniz-Laguna, A., Cuisset, J.-M., Guyant-Marechal, L., Aubourg, P., Kremer, L., Baaloul, N., Verloes, A., Beladgham, K., Perrot, J., Francou, B., et al. (2020) · neurogenetics · doi:10.1007/s10048-019-00596-z · Cited by 14
Schrom, E.-M., Moschall, R., Hartl, M. J., Weitner, H., Fecher, D., Langemeier, J., Bohne, J., Wöhrl, B. M., & Bodem, J. (2013) · Retrovirology · doi:10.1186/1742-4690-10-55 · Cited by 14
“Despite relatively low complementarity, bioinformatics analysis predicts that the MSD constitutes a strong 5′splice site [27,28].”
BackgroundQSOX2 Deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction
Maharaj, A. V., Ishida, M., Rybak, A., Elfeky, R., Andrews, A., Joshi, A., Elmslie, F., Joensuu, A., Kantojärvi, K., Jia, R. Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52587-w · Cited by 9
(2023) · doi:10.1002/pro.4576 · Cited by 5
Identification of a Novel Non-Canonical Splice-Site Variant in ABCD1
Zheng, F., Lin, Z., Hu, Y., Shi, X., Zhao, Q., & Lin, Z. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020473 · Cited by 1
Metadata
- Authors
- Desmet, F.-O., Hamroun, D., Lalande, M., Collod-Béroud, G., Claustres, M., & Béroud, C.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04-01
- Volume
- 37
- Issue
- 9
- Pages
- e67-e67
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2132123037
- Cited by
- 2,512
- References
- 85
- FWCI
- 30.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.